JoVE Logo

Sign In

5.12 : Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.

The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled back to methionine through a process referred to as remethylation.

Methylated products exhibit distinct characteristics. They are generally irreversible, highly polar, and water-soluble metabolites. While often less pharmacologically active than their parent drug due to decreased affinity for target receptors or enzymes, methylation can enhance or retain a drug's activity in some instances.

Several functional groups, including hydroxyl, amino, thiol, and carboxyl, can undergo methylation. A notable example is the drug codeine, which morphs into a more potent analgesic, morphine, via methylation. Similarly, the neurotransmitter dopamine can be methylated to produce epinephrine, a hormone that plays a pivotal role in the body's stress response.

To sum up, methylation is a significant biotransformation reaction integral to drug detoxification and elimination from the body. It transforms lipophilic drugs into polar metabolites that are readily excreted. Catalyzed by methyltransferase enzymes, methylation impacts various functional groups, resulting in altered pharmacological activity of the products.

Tags

MethylationPhase II ReactionsBiotransformationMethyltransferasesS adenosylmethionine SAMS adenosylhomocysteine SAHHomocysteineRemethylationMetabolitesDrug DetoxificationPharmacological ActivityFunctional GroupsCodeineMorphineDopamineEpinephrine

From Chapter 5:

article

Now Playing

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

149 Views

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

399 Views

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

245 Views

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

150 Views

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

69 Views

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

182 Views

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

80 Views

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

167 Views

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

311 Views

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

182 Views

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

156 Views

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

191 Views

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

48 Views

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

193 Views

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

123 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved